Quantitative Assessment of the in vivo Dissolution Rate to Establish a Modified IVIVC for Isosorbide Mononitrate Tablets.

Zhang, Guoqing; Zhang, Li; Tan, Yuexiang; Wang, Lei; Cheng, Zeneng

Zhang, Guoqing; Zhang, Li; Tan, Yuexiang; Wang, Lei; Cheng, Zeneng.

Affiliation

Zhang G; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China.
Zhang L; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China.
Tan Y; Hunan Huize Bio-pharmaceutical Co., Ltd, Changsha, Hunan 410000, China.
Wang L; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. Electronic address: wl@hz-pharm.com.
Cheng Z; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. Electronic address: chengzn@csu.edu.cn.

J Pharm Sci ; 112(6): 1705-1714, 2023 06.

Article de En | MEDLINE | ID: mdl-34728173

Sujet(s)
Mots clés

In vivo dissolution profile; In vivo dissolution rate constant; Isosorbide omononitrate; Modified IVIVC; The novel pharmacokinetic model

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dinitrate isosorbide Limites: Humans Langue: En Journal: J Pharm Sci Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google